On March 21, 2016, the Board of Directors of Petlife Pharmaceuticals, Inc. appointed Ralph T. Salvagno, M.D. to its Board of Directors and as the Chairman of the Board of Directors. Dr. Salvagno is a Board-Certified Orthopaedic Surgeon practicing in the Hagerstown, Maryland area.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | -.--% |
2020 | Petlife Pharmaceuticals, Inc. Announces Management Changes | CI |
2018 | Petlife Pharmaceuticals, Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 22.21T | |
+31.06% | 68TCr | |
+30.35% | 59TCr | |
-3.42% | 36TCr | |
+18.02% | 33TCr | |
+4.27% | 28TCr | |
+15.53% | 24TCr | |
+10.16% | 21TCr | |
-8.14% | 20TCr | |
+8.12% | 17TCr |
- Stock Market
- Equities
- PTLF Stock
- News Petlife Pharmaceuticals, Inc.
- Petlife Pharmaceuticals, Inc. Appoints Ralph T. Salvagno to its Board of Directors and as the Chairman of the Board of Directors